NCT02880410View on ClinicalTrials.gov

Feasibility Study on LITT for Newly Diagnosed Glioblastoma

PHASE1TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

August 15, 2017

Primary Completion Date

September 14, 2018

Study Completion Date

September 14, 2018

Conditions
Glioblastoma
Interventions
DEVICE

NeuroBlate System

Laser Interstitial Thermal Therapy

DRUG

Radiation therapy and temozolomide

Radiation therapy and temozolomide

Trial Locations (4)

27157

Wake Forest Baptist Health, Winston-Salem

44195

Cleveland Clinic Foundation, Cleveland

63110

Washington University, St Louis

77030

MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

Monteris Medical
All Listed Sponsors
lead

Monteris Medical

INDUSTRY

NCT02880410 - Feasibility Study on LITT for Newly Diagnosed Glioblastoma | Biotech Hunter | Biotech Hunter